VEGFA and inflammatory bowel disease: Moreover, the alteration of the microbiota in patients with IBD has been observed to result in increased expression of lipopolysaccharide, thereby activating a number of proinflammatory molecules (interleukine-6, interferon γ and vascular endothelial growth factor) that could contribute to the development of EIMs [8] (Figure 1).